ErbB receptor tyrosine kinase receptors as a therapeutic target in melanoma
4.4.2.Alpha and beta diversity were assessed for sex, clinical benefit after one year, RECIST, and best of response, analyzing differences between groups.Linear discriminant analysis (LDA) identified differences in microbial composition between groups.A Random Forest classifier was trained using the OTU abundance calculations, following the Qiime2 best practices guide.Results: The alpha diversity indices Chao1, Observed Features, and Shannon found significant differences with p.adjusted by Benjamini-Hochberg < 0.05 for the clinical benefit at year variable.This indicates that microbial population abundance could affect the response to immunotherapy.In the LefSe test, with an LDA score of 3, we identified ten bacterial genera that could predict good and poor responses to immunotherapy.
Authors
- A.-K. Jochum
- Tobias Sinnberg (ORCID: https://orcid.org/0000-0003-3922-3327)
- Oltin T. Pop (ORCID: https://orcid.org/0000-0001-8000-2310)
- Michael Hölzel (ORCID: https://orcid.org/0000-0003-4048-8824)
- Stephan Forchhammer (ORCID: https://orcid.org/0000-0002-1274-2613)
- Wolfram Jochum (ORCID: https://orcid.org/0000-0001-6170-2020)
- Christian M. Schürch (ORCID: https://orcid.org/0000-0002-1792-1768)
- Andrea Forschner (ORCID: https://orcid.org/0000-0002-6185-4945)
- U. Leiter-Stöppke
- Teresa Amaral (ORCID: https://orcid.org/0000-0002-2516-5181)
- Heike Niessner (ORCID: https://orcid.org/0000-0002-2542-7022)
- Lukas Flatz (ORCID: https://orcid.org/0000-0001-9683-8390)
- Roland H. Wenger (ORCID: https://orcid.org/0000-0001-7592-4839)
- Antonio Cozzio (ORCID: https://orcid.org/0000-0002-8299-1746)
- Markus Jörger
- A. Nurmammadova
- B. Broske
Institutions
- University Hospital Bonn (DE)
- Kantonsspital St. Gallen (CH)
- University Children's Hospital Tübingen (DE)
- Kantonsspital Graubünden (CH)
- Charité - Universitätsmedizin Berlin (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100492
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00